ProPublica updated its Dollars for Docs database that features payments companies made to physicians from August 2013 through December 2015.
Dollars for Docs lists the following 10 drugs for which companies paid the most in payments to physicians last year:
1. Xarelto (a blood thinner) — $28.4 million
2. Humira (rheumatoid arthritis drug) — $24.9 million
3. Invokana (drug for diabetes) — $20.9 million
4. Viekira (hepatitis C drug) — $19.2 million
5. Eliquis (blood thinner) — $18.8 million
6. Bydureon (diabetes drug) — $18.5 million
7. Androgel (testosterone drug)— $15.3 million
8. Synthroid (thyroid drug)—$14.7 million
9. Lupron (synthetic hormone) — $14.3 million
10. Victoza (diabetes drug)— $11.9 million
